Dr Che-hsu to lead Appier as Chief Strategy Officer

Spread the love

Taipei, Taiwan: Former top executive of McKinsey, Dr Che-hsu to lead Appier as Chief Strategy Officer (CSO). The AI SaaS company Appier has appointed Dr Che-hsu “Joe” Chang as the CSO.

Dr Chang is a business veteran with more than 12 years of experience in business strategy, product management and management consulting.

He will help drive the company’s growth, strengthen its strategic deployment in the AI market, and pace up new market expansion and product innovation.

Dr Che-hsu to lead Appier as CSO

As CSO, Dr Chang will lead Appier‘s mergers and acquisitions (M&A), partnership and corporate strategy. He will also oversee the company’s overall business health and growth opportunities globally.

He is based in New York and New Jersey, US, and will be partnering with Appier’s senior leaders across business units and regions, strategizing for global opportunities that can propel Appier’s growth, especially in new markets.

“I am delighted to welcome Dr Joe Chang to Appier. Joe’s multifaceted experience in corporate strategy makes him the best fit to lead Appier’s growth strategy and accelerate our success,” said Dr Chih-han Yu, CEO and Co-Founder of Appier.

“With Joe on our team, I believe we will be able to explore more business possibilities to help us stay competitive and enhance our overall capacity for rapid growth in 2022 and beyond,” added Dr Yu.

“Appier is a rapidly growing AI SaaS company with a strong focus on customer-centric marketing solutions. I’m thrilled to be part of Appier and look forward to working with world-class talents to drive business and organisational growth as well as efficiency,” said Dr Chang.

“I am eager to bring my experiences in industries, businesses and technologies to the new role to build upon Appier’s success and sustain long-term growth,” he added.

Started at McKinsey and Co.

Dr Chang was most recently the Senior Principal of Real World Technology Solutions Strategy at IQVIA. He began his career at McKinsey and Co. in the US, where he co-led and grew the company’s healthcare and business technology practices as an Associate Partner.

He also led research operations and product development at Flatiron Health, a startup acquired by Roche in 2018. Dr Chang holds a Doctor of Science degree in Public Health from Harvard University and a Master of Science and Bachelor of Science degree from National Taiwan University.

Leave a Reply

Your email address will not be published. Required fields are marked *